jamp-fosfomycin powder for solution
jamp pharma corporation - fosfomycin (fosfomycin tromethamine) - powder for solution - 3g - fosfomycin (fosfomycin tromethamine) 3g - urinary anti-infectives
fosfomycin powder for oral solution powder for solution
endo ventures ltd. - fosfomycin (fosfomycin tromethamine) - powder for solution - 3g - fosfomycin (fosfomycin tromethamine) 3g - urinary anti-infectives
fosfomycin tromethamine- granules for oral solution powder
xiromed llc - fosfomycin tromethamine (unii: 7fxw6u30gy) (fosfomycin - unii:2n81my12te) - fosfomycin tromethamine is indicated only for the treatment of uncomplicated urinary tract infections (acute cystitis) in women due to susceptible strains of escherichia coli and enterococcus faecalis . fosfomycin tromethamine is not indicated for the treatment of pyelonephritis or perinephric abscess. if persistence or reappearance of bacteriuria occurs after treatment with fosfomycin tromethamine, other therapeutic agents should be selected. (see precautions and clinical studies sections.) fosfomycin tromethamine is contraindicated in patients with known hypersensitivity to the drug.
fosfomycin tromethamine powder
zambon usa, ltd - fosfomycin tromethamine (unii: 7fxw6u30gy) (fosfomycin - unii:2n81my12te) - fosfomycin tromethamine is indicated only for the treatment of uncomplicated urinary tract infections (acute cystitis) in women due to susceptible strains of escherichia coli and enterococcus faecalis . fosfomycin tromethamine is not indicated for the treatment of pyelonephritis or perinephric abscess. if persistence or reappearance of bacteriuria occurs after treatment with fosfomycin tromethamine, other therapeutic agents should be selected. (see precautions and clinical studies sections.) fosfomycin tromethamine is contraindicated in patients with known hypersensitivity to the drug.
fosfomycin tromethamine granule, for solution
ascend laboratories, llc - fosfomycin tromethamine (unii: 7fxw6u30gy) (fosfomycin - unii:2n81my12te) - fosfomycin tromethamine granules for oral solution is indicated only for the treatment of uncomplicated urinary tract infections (acute cystitis) in women due to susceptible strains of escherichia coli and enterococcus faecalis . fosfomycin tromethamine granules for oral solution is not indicated for the treatment of pyelonephritis or perinephric abscess. if persistence or reappearance of bacteriuria occurs after treatment with fosfomycin tromethamine granules for oral solution, other therapeutic agents should be selected. (see precautions and clinical studies sections.) fosfomycin tromethamine is contraindicated in patients with known hypersensitivity to the drug.
fosfomycin tromethamine granule, for solution
cipla usa inc. - fosfomycin tromethamine (unii: 7fxw6u30gy) (fosfomycin - unii:2n81my12te) - fosfomycin tromethamine granules for oral solution is indicated only for the treatment of uncomplicated urinary tract infections (acute cystitis) in women due to susceptible strains of escherichia coli and enterococcus faecalis . fosfomycin tromethamine granules for oral solution is not indicated for the treatment of pyelonephritis or perinephric abscess. if persistence or reappearance of bacteriuria occurs after treatment with fosfomycin tromethamine granules for oral solution, other therapeutic agents should be selected. (see precautions and clinical studies sections.) fosfomycin tromethamine granules for oral solution is contraindicated in patients with known hypersensitivity to the drug.
fosfomycin tromethamine granule, for solution
bryant ranch prepack - fosfomycin tromethamine (unii: 7fxw6u30gy) (fosfomycin - unii:2n81my12te) - fosfomycin tromethamine granules for oral solution is indicated only for the treatment of uncomplicated urinary tract infections (acute cystitis) in women due to susceptible strains of escherichia coli and enterococcus faecalis . fosfomycin tromethamine granules for oral solution is not indicated for the treatment of pyelonephritis or perinephric abscess. if persistence or reappearance of bacteriuria occurs after treatment with fosfomycin tromethamine granules for oral solution, other therapeutic agents should be selected. (see precautions and clinical studies sections.) fosfomycin tromethamine is contraindicated in patients with known hypersensitivity to the drug.
fosfomycin tromethamine- granules for oral powder
a-s medication solutions - fosfomycin tromethamine (unii: 7fxw6u30gy) (fosfomycin - unii:2n81my12te) - fosfomycin tromethamine is indicated only for the treatment of uncomplicated urinary tract infections (acute cystitis) in women due to susceptible strains of escherichia coli and enterococcus faecalis . fosfomycin tromethamine is not indicated for the treatment of pyelonephritis or perinephric abscess. if persistence or reappearance of bacteriuria occurs after treatment with fosfomycin tromethamine, other therapeutic agents should be selected. (see precautions and clinical studies sections.) fosfomycin tromethamine is contraindicated in patients with known hypersensitivity to the drug.
fosfomycin tromethamine granule, for solution
a-s medication solutions - fosfomycin tromethamine (unii: 7fxw6u30gy) (fosfomycin - unii:2n81my12te) - fosfomycin tromethamine granules for oral solution is indicated only for the treatment of uncomplicated urinary tract infections (acute cystitis) in women due to susceptible strains of escherichia coli and enterococcus faecalis . fosfomycin tromethamine granules for oral solution is not indicated for the treatment of pyelonephritis or perinephric abscess. if persistence or reappearance of bacteriuria occurs after treatment with fosfomycin tromethamine granules for oral solution, other therapeutic agents should be selected. (see precautions and clinical studies sections.) fosfomycin tromethamine is contraindicated in patients with known hypersensitivity to the drug.
monurol- fosfomycin tromethamine powder
allergan, inc. - fosfomycin tromethamine (unii: 7fxw6u30gy) (fosfomycin - unii:2n81my12te) - fosfomycin 3 g - monurol is indicated only for the treatment of uncomplicated urinary tract infections (acute cystitis) in women due to susceptible strains of escherichia coli and enterococcus faecalis . monurol is not indicated for the treatment of pyelonephritis or perinephric abscess. if persistence or reappearance of bacteriuria occurs after treatment with monurol, other therapeutic agents should be selected. (see precautions and clinical studies sections.) monurol is contraindicated in patients with known hypersensitivity to the drug.